[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 25, Issue 4 (Bimonthly 2021) ::
Feyz 2021, 25(4): 1055-1063 Back to browse issues page
The effect of selenium supplementation on the expression of some of the genes associated with inflammatory markers in diabetic hemodialysis patients
Atefeh Jamal , Seyed Morteza Seifati , Mahmoud Dehghani Ashkezari , Alireza Soleimani
, seifati@gmail.com
Abstract:   (1087 Views)
Background: Kidney damage is one of the most common complications of diabetes that can eventually lead to hemodialysis. Inflammation is one of the effective factors in the development of this complication. Considering the strong anti-inflammatory effects of selenium supplementation, the aim of this study was to determine the effect of this supplementation on the expression levels of inflammation-related genes in diabetic hemodialysis patients.
Materials and methods: This randomized, double-blind, placebo-controlled clinical trial was performed in 40 diabetic hemodialysis patients. Participants were randomly divided into two groups to take either 200 µg/day selenium (n=20) or placebo (n=20) for 3 months.
Results: Selenium supplementation upregulated transforming growth factor beta (TGF-β) (P=0.002) gene expression levels. This intervention also decreased gene expression of tumor necrosis factor alpha (TNF-α) (P=0.01) and interleukin-1 (IL-1) (P=0.02) compared with the placebo. In this study gene expression of vascular endothelial growth factor (VEGF) (P=0.33) and (IL-8) (P=0.45) were not affected by selenium supplementation.
Conclusion: Selenium supplementation during 3 months to diabetic hemodialysis patients had beneficial effects on gene expression related to inflammatory markers.
Keywords: Selenium, Anti-inflammatory agent, Hemodialysis, Diabetes, Inflammation, TNF-alpha, TGF-beta
Full-Text [PDF 965 kb]   (586 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2021/06/21 | Revised: 2021/10/18 | Accepted: 2021/08/24 | Published: 2021/10/2
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jamal A, Seifati S M, Dehghani Ashkezari M, Soleimani A. The effect of selenium supplementation on the expression of some of the genes associated with inflammatory markers in diabetic hemodialysis patients. Feyz 2021; 25 (4) :1055-1063
URL: http://feyz.kaums.ac.ir/article-1-4418-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 25, Issue 4 (Bimonthly 2021) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4642